Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Anthrax vaccines: past, present and future.

Turnbull PC.

Vaccine. 1991 Aug;9(8):533-9. Review.

PMID:
1771966
2.

Anthrax: the disease in relation to vaccines.

Hambleton P, Carman JA, Melling J.

Vaccine. 1984 Jun;2(2):125-32. Review.

PMID:
6442500
3.

Human live anthrax vaccine in the former USSR.

Shlyakhov EN, Rubinstein E.

Vaccine. 1994 Jun;12(8):727-30.

PMID:
8091851
4.

[Vaccines against anthrax in animals, from Louis Pasteur to our day].

Shlyakhov E, Blancou J, Rubinstein E.

Rev Sci Tech. 1996 Sep;15(3):853-62. French.

PMID:
9376647
5.

[On the 100th anniversary of L. S. Tsenkovskiĭ's development of the method of producing an attenuated vaccine against anthrax].

Diachenko SS.

Mikrobiol Zh. 1984 Nov-Dec;46(6):93-6. Russian. No abstract available.

PMID:
6443874
6.

[Preparation, control and application of anthrax vaccine in USSR].

Romanov GI.

Arch Exp Veterinarmed. 1980;34(1):119-22. German.

PMID:
6774689
7.

Adaptation to environment--the Pasteur anthrax vaccine in Australia.

Todd JH.

Aust Vet J. 1992 Dec;69(12):318-21. No abstract available.

PMID:
1492828
8.

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

Welkos S, Little S, Friedlander A, Fritz D, Fellows P.

Microbiology. 2001 Jun;147(Pt 6):1677-85.

PMID:
11390699
11.
12.

BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge.

Köhler SM, Baillie LW, Beyer W.

Vaccine. 2015 Jun 4;33(24):2771-7. doi: 10.1016/j.vaccine.2015.04.049. Epub 2015 Apr 24.

PMID:
25917676
13.

Anthrax vaccines: a development update.

Little SF.

BioDrugs. 2005;19(4):233-45. Review.

PMID:
16128606
14.

The development of new vaccines against Bacillus anthracis.

Baillie L.

J Appl Microbiol. 2001 Oct;91(4):609-13. Review. No abstract available.

15.

Immunizing activity of oil adjuvant attenuated spore vaccine of Bacillus anthracis in sheep.

Al-Dabbass AH, Al-Abdali SM, Mahmoud AA, Muhamed MM.

Zentralbl Veterinarmed B. 1986 Jun;33(5):340-5. No abstract available.

PMID:
3096031
16.

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.

PMID:
17005989
17.

Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.

Shakya KP, Hugh-Jones ME, Elzer PH.

Vaccine. 2007 Jul 20;25(29):5374-7. Epub 2007 May 22.

PMID:
17555849
18.

Anthrax vaccine development: a continuing story.

Hambleton P, Turnbull PC.

Adv Biotechnol Processes. 1990;13:105-22. Review. No abstract available.

PMID:
1692223
19.

Antigen delivery by attenuated Bacillus anthracis: new prospects in veterinary vaccines.

Brossier F, Mock M, Sirard JC.

J Appl Microbiol. 1999 Aug;87(2):298-302.

20.

Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.

Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.

Vaccine. 2005 Dec 1;23(48-49):5688-97. Epub 2005 Feb 5.

PMID:
16039760

Supplemental Content

Support Center